Compositions and methods for inhibition of the JAK pathway

1. A compound of formula I:

or a solvate or pharmaceutically acceptable salt thereof, wherein:

X is selected from the group consisting of alkyl, substituted alkyl, alkoxy, substituted alkoxy, amino, substituted amino, carboxyl, carboxyl ester, cyano, halo, nitro, alkenyl, substituted alkenyl, alkynyl and substituted alkynyl;

Y is selected from the group consisting of hydrogen, alkyl substituted alkyl, amino, substituted amino, and halo;

R is selected from the group consisting of hydrogen, alkyl, substituted alkyl, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, cycloalkyl and substituted cycloalkyl;

ring A is selected from the group consisting of aryl, heteroaryl, cycloalkyl, cycloalkenyl and heterocyclic, wherein ring A is not indolyl or benzimidazolyl;

p is 0, 1, 2 or 3;

q is 1, 2 or 3 when ring A is a single ring, or q is 0, 1, 2, 3, 4, or 5 when ring A comprises multiple rings;

each R 2 independently is selected from the group consisting of alkyl, substituted alkyl, alkoxy, —O-(substituted alkyl), —O-(substituted alkenyl), —O-(substituted alkynyl), amino, substituted amino, aryl, substituted aryl, aryloxy, substituted aryloxy, cycloalkyl, substituted cycloalkyl, heteroaryl, substituted heteroaryl, heterocyclic, substituted heterocyclic, heterocyclyloxy, substituted carboxyl, carboxyl ester, hydroxyl, acylamino, aminosufonyl, alkynyl, substituted alkynyl, alkylthio, substituted alkylthio, aminocarbonyl, acyl, oxo, and halo,

wherein alkyl substituents for —O-(substituted alkyl) are selected from alkoxy, substituted alkoxy, acyl, acylamino, acyloxy, amino, substituted amino, aminocarbonyl, aminothiocarbonyl, aminocarbonylamino, aminothiocarbonylamino, aminocarbonyloxy, aminosulfonyl, aminosulfonyloxy, sulfonylamino, aminosulfonylamino, amidino, aryl, substituted aryl, aryloxy, substituted aryloxy, arylthio, substituted arylthio, carboxyl, carboxyl ester, (carboxyl ester)amino, (carboxyl ester)oxy, cyano, cycloalkyl, substituted cycloalkyl, cycloalkyloxy, substituted cycloalkyloxy, cycloalkylthio, substituted cycloalkylthio, cycloalkenyl, substituted cycloalkenyl, cycloalkenyloxy, substituted cycloalkenyloxy, cycloalkenylthio, substituted cycloalkenylthio, guanidino, substituted guanidino, halo, hydroxy, heteroarylthio, substituted heteroarylthio, heterocyclic, substituted heterocyclic, heterocyclyloxy, substituted heterocyclyloxy, heterocyclylthio, substituted heterocyclylthio, nitro, SO 3 H, sulfonyl, sulfonyloxy, thioacyl, thiol, alkylthio, and substituted alkylthio;

each R 3 independently is selected from the group consisting of alkyl, substituted alkyl, cycloalkyl, substituted cycloalkyl, heterocyclic, substituted heterocyclic, halo, and aminosulfonyl; and

R 4 and R 5 independently are selected from the group consisting of hydrogen, alkyl, substituted alkyl, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, alkoxy, cycloalkyl, substituted cycloalkyl, and acyl; or

R 4 and R 5 together with the nitrogen atom bound thereto, form a heterocyclic or substituted heterocyclic group;

provided that:

if q=0, then X is not bromo;

if ring A is cycloalkyl, then X is not bromo;

if q=2 and each of R 2 is methoxy, halo, trihalomethyl or trihalomethoxy, then R 4 and R 5 are not one hydrogen and one methyl;

if q=2 and R 2 is fluoro and methyl, then R is not substituted alkenyl; and

if ring A is phenyl, q=1 and R 2 is chloro, then R 4 and R 5 are not one hydrogen and one methyl.

2. A method, comprising administering to a subject an effective amount of a compound having a formula I

or a solvate or pharmaceutically acceptable salt thereof, wherein:

X is selected from the group consisting of alkyl, substituted alkyl, alkoxy, substituted alkoxy, amino, substituted amino, carboxyl, carboxyl ester, cyano, halo, nitro, alkenyl, substituted alkenyl, alkynyl and substituted alkynyl;

Y is selected from the group consisting of hydrogen, alkyl substituted alkyl, amino, substituted amino, and halo;

R is selected from the group consisting of hydrogen, alkyl, substituted alkyl, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, cycloalkyl and substituted cycloalkyl;

ring A is selected from the group consisting of aryl, heteroaryl, cycloalkyl, cycloalkenyl and heterocyclic, wherein ring A is not indolyl or benzimidazolyl;

p is 0, 1, 2 or 3;

q is 1, 2 or 3 when ring A is a single ring, or q is 0, 1, 2, 3, 4, or 5 when ring A comprises multiple rings;

each R 2 independently is selected from the group consisting of alkyl, substituted alkyl, alkoxy, —O-(substituted alkyl), —O-(substituted alkenyl), —O-(substituted alkynyl), amino, substituted amino, aryl, substituted aryl, aryloxy, substituted aryloxy, cycloalkyl, substituted cycloalkyl, heteroaryl, substituted heteroaryl, heterocyclic, substituted heterocyclic, heterocyclyloxy, substituted carboxyl, carboxyl ester, hydroxyl, acylamino, aminosufonyl, alkynyl, substituted alkynyl, alkylthio, substituted alkylthio, aminocarbonyl, acyl, oxo, and halo,

wherein substituents for —O-(substituted alkyl) are selected from alkoxy, substituted alkoxy, acyl, acylamino, acyloxy, amino, substituted amino, aminocarbonyl, aminothiocarbonyl, aminocarbonylamino, aminothiocarbonylamino, aminocarbonyloxy, aminosulfonyl, aminosulfonyloxy, sulfonylamino, aminosulfonylamino, amidino, aryl, substituted aryl, aryloxy, substituted aryloxy, arylthio, substituted arylthio, carboxyl, carboxyl ester, (carboxyl ester)amino, (carboxyl ester)oxy, cyano, cycloalkyl, substituted cycloalkyl, cycloalkyloxy, substituted cycloalkyloxy, cycloalkylthio, substituted cycloalkylthio, cycloalkenyl, substituted cycloalkenyl, cycloalkenyloxy, substituted cycloalkenyloxy, cycloalkenylthio, substituted cycloalkenylthio, guanidino, substituted guanidino, halo, hydroxy, heteroarylthio, substituted heteroarylthio, heterocyclic, substituted heterocyclic, heterocyclyloxy, substituted heterocyclyloxy, heterocyclylthio, substituted heterocyclylthio, nitro, SO 3 H, sulfonyl, sulfonyloxy, thioacyl, thiol, alkylthio, and substituted alkylthio;

each R 3 independently is selected from the group consisting of alkyl, substituted alkyl, cycloalkyl, substituted cycloalkyl, heterocyclic, substituted heterocyclic, halo, and aminosulfonyl; and

R 4 and R 5 independently are selected from the group consisting of hydrogen, alkyl, substituted alkyl, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, alkoxy, cycloalkyl, substituted cycloalkyl, and acyl; or

R 4 and R 5 together with the nitrogen atom bound thereto, form a heterocyclic or substituted heterocyclic group;

provided that:

if q=0, then X is not bromo;

if ring A is cycloalkyl, then X is not bromo;

if q=2 and each of R 2 is methoxy, halo, trihalomethyl or trihalomethoxy, then R 4 and R 5 are not one hydrogen and one methyl;

if q=2 and R 2 is fluoro and methyl, then R is not substituted alkenyl; and

if ring A is phenyl, q=1 and R 2 is chloro, then R 4 and R 5 are not one hydrogen and one methyl.

3. The compound according to claim 1 , wherein:

ring A is selected from,

and

Q is selected from C, N, O, or S.

4. The compound according to claim 1 wherein ring A is phenyl.

5. The compound according to claim 1 wherein R is H, C 1 -C 6 alkyl, or —CH 2 C(O)OCH 2 CH 3 .

6. The compound according to claim 1 wherein at least one R 2 is alkynyl or alkynyloxy.

7. The compound according to claim 1 wherein at least one R 2 is halo, —OCH 3 , —OH, —CH 3 , —NHC(O)CH 3 , —OCH 2 CCH, —OCH 2 CH 2 CCH, —NHCH 2 CCH, —CH 2 NHC(O)OCH 2 CCH, —SO 2 NHCH 2 CCH, 1H-benzo(d)imidazol-2-yl, 1H-(benzo(d)imidazol-2-yl)methyl, benzonitrile, 1-(phenyl-1H-1,2,3-triazol-4-yl)methoxy, pyridinyl, pyridine-4-yl-methyl, pyridinylmethoxy, pyridine-4-yl-methylthio, pyrimidinyl, pyrimidinylmethoxy, —CCH, or cyanoethyl.

8. The compound according to claim 1 wherein R 2 is at the 3 and/or 4 position of the A ring.

9. The compound according to claim 1 wherein R 2 is C 1 -C 6 alkyl.

10. The compound according to claim 9 wherein R 2 is methyl.

11. A compound of formula I

or a solvate or pharmaceutically acceptable salt thereof, wherein:

X is halo, cyano, C 1 -C 6 alkyl, CF 3 , or NO 2 ;

Y is selected from the group consisting of hydrogen, alkyl substituted alkyl, amino, substituted amino, and halo;

R is selected from the group consisting of hydrogen, alkyl, substituted alkyl, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, cycloalkyl and substituted cycloalkyl;

ring A is phenyl or 3-oxo-1,4-benzothiazin-6-yl;

p is 0, 1, 2 or 3;

q is 1, 2 or 3 when ring A is phenyl, or q is 0, 1, 2, 3, 4, or 5 when ring A is 3-oxo-1,4-benzothiazin-6-yl;

each R 2 independently is selected from the group consisting of alkyl, substituted alkyl, alkoxy, —O-(substituted alkyl), —O-(substituted alkenyl), —O-(substituted alkynyl), amino, substituted amino, aryl, substituted aryl, aryloxy, substituted aryloxy, cycloalkyl, substituted cycloalkyl, heteroaryl, substituted heteroaryl, heterocyclic, substituted heterocyclic, heterocyclyloxy, substituted carboxyl, carboxyl ester, hydroxyl, acylamino, aminosufonyl, alkynyl, substituted alkynyl, alkylthio, substituted alkylthio, aminocarbonyl, acyl, oxo, and halo,

wherein alkyl substituents for —O-(substituted alkyl) are selected from alkoxy, substituted alkoxy, acyl, acylamino, acyloxy, amino, substituted amino, aminocarbonyl, aminothiocarbonyl, aminocarbonylamino, aminothiocarbonylamino, aminocarbonyloxy, aminosulfonyl, aminosulfonyloxy, sulfonylamino, aminosulfonylamino, amidino, aryl, substituted aryl, aryloxy, substituted aryloxy, arylthio, substituted arylthio, carboxyl, carboxyl ester, (carboxyl ester)amino, (carboxyl ester)oxy, cyano, cycloalkyl, substituted cycloalkyl, cycloalkyloxy, substituted cycloalkyloxy, cycloalkylthio, substituted cycloalkylthio, cycloalkenyl, substituted cycloalkenyl, cycloalkenyloxy, substituted cycloalkenyloxy, cycloalkenylthio, substituted cycloalkenylthio, guanidino, substituted guanidino, halo, hydroxy, heteroarylthio, substituted heteroarylthio, heterocyclic, substituted heterocyclic, heterocyclyloxy, substituted heterocyclyloxy, heterocyclylthio, substituted heterocyclylthio, nitro, SO 3 H, sulfonyl, sulfonyloxy, thioacyl, thiol, alkylthio, and substituted alkylthio;

each R 3 independently is selected from the group consisting of alkyl, substituted alkyl, cycloalkyl, substituted cycloalkyl, heterocyclic, substituted heterocyclic, halo, and aminosulfonyl; and

R 4 and R 5 independently are selected from the group consisting of hydrogen, alkyl, substituted alkyl, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, alkoxy, cycloalkyl, substituted cycloalkyl, and acyl;

provided that:

if q=0, then X is not bromo;

if q=2 and each of R 2 is methoxy, halo, trihalomethyl or trihalomethoxy, then R 4 and R 5 are not one hydrogen and one methyl;

if q=2 and R 2 is fluoro and methyl, then R is not substituted alkenyl; and

if ring A is phenyl, q=1 and R 2 is chloro, then R 4 and R 5 are not one hydrogen and one methyl.

12. The compound according to claim 1 , wherein:

X is fluoro, cyano or C 1 -C 6 alkyl; and

q is 1 or 2.

13. The compound according to claim 1 , wherein Y is H.

14. The compound according to claim 1 wherein Y is hydrogen and X is fluoro.

15. The compound according to claim 1 wherein at least one R 3 is H or C 1 -C 6 alkyl.

16. The compound according to claim 1 wherein at least one R 3 is methyl, isopropyl, or piperizinyl.

17. A compound of formula I

or a solvate or pharmaceutically acceptable salt thereof, wherein:

X is selected from the group consisting of alkyl, substituted alkyl, alkoxy, substituted alkoxy, amino, substituted amino, carboxyl, carboxyl ester, cyano, halo, nitro, alkenyl, substituted alkenyl, alkynyl and substituted alkynyl;

Y is selected from the group consisting of hydrogen, alkyl substituted alkyl, amino, substituted amino, and halo;

R is selected from the group consisting of hydrogen, alkyl, substituted alkyl, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, cycloalkyl and substituted cycloalkyl;

ring A is selected from the group consisting of aryl, heteroaryl, cycloalkyl, cycloalkenyl and heterocyclic, wherein ring A is not indolyl or benzimidazolyl;

p is 0, 1, 2 or 3;

q is 1, 2 or 3 when ring A is a single ring, or q is 0, 1, 2, 3, 4, or 5 when ring A comprises multiple rings;

each R 2 independently is selected from the group consisting of alkyl, substituted alkyl, alkoxy, —O-(substituted alkyl), —O-(substituted alkenyl), —O-(substituted alkynyl), amino, substituted amino, aryl, substituted aryl, aryloxy, substituted aryloxy, cycloalkyl, substituted cycloalkyl, heteroaryl, substituted heteroaryl, heterocyclic, substituted heterocyclic, heterocyclyloxy, substituted carboxyl, carboxyl ester, hydroxyl, acylamino, aminosufonyl, alkynyl, substituted alkynyl, alkylthio, substituted alkylthio, aminocarbonyl, acyl, oxo, and halo,

wherein alkyl substituents for —O-(substituted alkyl) are selected from alkoxy, substituted alkoxy, acyl, acylamino, acyloxy, amino, substituted amino, aminocarbonyl, aminothiocarbonyl, aminocarbonylamino, aminothiocarbonylamino, aminocarbonyloxy, aminosulfonyl, aminosulfonyloxy, sulfonylamino, aminosulfonylamino, amidino, aryl, substituted aryl, aryloxy, substituted aryloxy, arylthio, substituted arylthio, carboxyl, carboxyl ester, (carboxyl ester)amino, (carboxyl ester)oxy, cyano, cycloalkyl, substituted cycloalkyl, cycloalkyloxy, substituted cycloalkyloxy, cycloalkylthio, substituted cycloalkylthio, cycloalkenyl, substituted cycloalkenyl, cycloalkenyloxy, substituted cycloalkenyloxy, cycloalkenylthio, substituted cycloalkenylthio, guanidino, substituted guanidino, halo, hydroxy, heteroarylthio, substituted heteroarylthio, heterocyclic, substituted heterocyclic, heterocyclyloxy, substituted heterocyclyloxy, heterocyclylthio, substituted heterocyclylthio, nitro, SO 3 H, sulfonyl, sulfonyloxy, thioacyl, thiol, alkylthio, and substituted alkylthio;

each R 3 independently is selected from the group consisting of alkyl, substituted alkyl, cycloalkyl, substituted cycloalkyl, heterocyclic, substituted heterocyclic, halo, and aminosulfonyl; and

the —SO 2 N(R 4 )(R 5 ) group is

—SO 2 NH 2 , —SO 2 NH(CH 3 ), —SO 2 N(CH 3 ) 2 , —SO 2 NHC(O)Et, —SO 2 NHCH 2 CCH, —SO 2 NH—OC(CH 3 ) 3 , —SO 2 NHC(O)-isopropyl, —SO 2 NHC(O)-n-propyl, —SO 2 NHC(O)-butyl, or —SO 2 NHC(O)-pentyl;

provided that:

if q=0, then X is not bromo;

if ring A is cycloalkyl, then X is not bromo;

if q=2 and each of R 2 is methoxy, halo, trihalomethyl or trihalomethoxy, then R 4 and R 5 are not one hydrogen and one methyl;

if q=2 and R 2 is fluoro and methyl, then R is not substituted alkenyl; and

if ring A is phenyl, q=1 and R 2 is chloro, then R 4 and R 5 are not one hydrogen and one methyl.

18. The compound according to claim 1 wherein ring A is phenyl and R 2 is propynyl or propynyloxy.

19. The compound according to claim 1 , wherein:

R is H;

at least one R 2 is halo, —OCH 3 , —OH, —CH 3 , —NHC(O)CH 3 , —OCH 2 CCH, —OCH 2 CH 2 CCH, —NHCH 2 CCH, —CH 2 NHC(O)OCH 2 CCH, —SO 2 NHCH 2 CCH, 1H-benzo(d)imidazol-2-yl, 1H-(benzo(d)imidazol-2-yl)methyl, benzonitrile, 1-(phenyl-1H-1,2,3-triazol-4-yl)methoxy, pyridinyl, pyridine-4-yl-methyl, pyridinylmethoxy, pyridine-4-yl-methylthio, pyrimidinyl, pyrimidinylmethoxy, —CCH, or cyanoethyl;

X is H, F, —CH 3 or —CF 3 ;

Y is H;

R 3 is H, C 1 -C 6 alkyl or halo; and

—SO 2 N(R 4 )(R 5 ) is —SO 2 NH 2 , SO 2 NH(CH 3 ), —SO 2 N(CH 3 ) 2 , —SO 2 NHC(O)Et, —SO 2 NHCH 2 CCH, —SO 2 NH—OC(CH 3 ) 3 , —SO 2 NHC(O)-isopropyl, —SO 2 NHC(O)-n-propyl, —SO 2 NHC(O)-butyl, or —SO 2 NHC(O)-pentyl.